Created at 2:25 p.m. Apr, 16, 2025
Author: zrk_zrk
Related Note: 1473986034094 3
Rationale for change

Pretty sure shape change is via p2y1, not p2y12. p2y12 is the degranulation, txa2 synthesis, and gpIIb/IIIa synthesis

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Pathoma::04_Hemostasis::01_Primary_Hemostasis_&_Related_Bleeding_Disorders #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::06_Platelets::02_Primary_Hemostasis #AK_Step1_v12::^Systems::HemeOnc::Hematology #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::03_Physiology::03_Platelet_plug_formation_(primary_hemostasis)::*Adhesion_Activation #AK_Other::#AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Hematology_&_Oncology::Pathoma_Hematology #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Hematology-Oncology::Approach_To_Bleeding #AK_Other::^EXPN::BGedit #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::03_Physiology::04_Thrombogenesis #AK_Other::Only_Step_1 #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::03_Antiplatelet,_Anticoagulant,_Thrombolytic_Agents #AK_Step1_v12::#Pixorize::01_Biochemistry::18_Platelet_Disorders::01_Platelet_Plug_Formation #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::01_Anticoagulants_&_Thrombolytics::03_Antiplatelet_agents #AK_Step1_v12::#B&B::12_Hematology::01_Hemostasis::02_Platelet_Activation #AK_Step1_v12::#Physeo::11_Pathology::10_HemeOnc_Pathology::01_Primary_Hemostasis